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Carcinoembryonic antigen (CEA) is a widely used tumor marker, especially in the surveillance of colonic
cancer patients. Although CEA is also present in some normal tissues, it is apparently expressed at higher levels
in tumorous tissues than in corresponding normal tissues. As a first step toward analyzing the regulation of
expression of CEA at the transcriptional level, we have isolated and characterized a cosmid clone (cosCEAl),
which contains the entire coding region of the CEA gene. A close correlation exists between the exon and
deduced immunoglobulin-like domain borders. We have determined a cluster of transcriptional starts for CEA
and the closely related nonspecffic cross-reacting antigen (NCA) gene and have sequenced their putative
promoters. Regions of sequence homology are found as far as approximately 500 nucleotides upstream from the
translational starts of these genes, but farther upstream they diverge completely. In both cases we were unable
to find classic TATA or CAAT boxes at their expected positions. To characterize the CEA and NCA promoters,
we carried out transient transfection assays with promoter-indicator gene constructs in the CEA-producing
adenocarcinoma cell line SW403, as well as in nonproducing HeLa cells. A CEA gene promoter construct,
containing approximately 400 nucleotides upstream from the translational start, showed nine times higher
activity in the SW403 than in the HeLa cell line. This indicates that cis-acting sequences which convey cell
type-specific expression of the CEA gene are contained within this region.
The carcinoembryonic antigen (CEA) was originally de-
scribed as a glycoprotein molecule with an oncofetal expres-
sion pattern (13). Recent experiments indicate that CEA may
function as a cell adhesion molecule, which could play an
important role during embryogenesis and possibly also dur-
ing tumor development (5). Despite its presence in some
normal tissues, its concentration in serum is a clinically
useful parameter, especially in the postoperative monitoring
of colonic tumor patients (52). CEA is a member of a family
of closely related molecules, whose genes reveal a high
degree of sequence similarity (reviewed in reference 49). The
CEA family shows structural resemblance to, and can be
placed within, the immunoglobulin superfamily (4, 32, 37).
The CEA family members are made up of one N-terminal
immunoglobulin variable-like, and a varying number of
immunoglobulin constant-like domains, according to the
classification of Williams (57). The CEA gene family can be
divided into two main subgroups based on sequence com-
parisons. One subgroup contains the CEA gene itself (2, 4,
36, 59) and those encoding the classic CEA immunocross-
reacting antigens, such as the nonspecific cross-reacting
antigens (NCA) (2, 31, 35, 47, 51) and biliary glycoprotein (3,
17). These molecules are membrane bound, either as integral
proteins such as biliary glycoprotein or after posttransla-
tional modification through a covalently linked glycosyl
phosphatidylinositol moiety as shown for CEA (16, 19, 45)
and an NCA (15, 21). The second subgroup contains the
genes encoding the pregnancy-specific glycoproteins (PSG),
which were recently shown to have homology to the CEA
subgroup members (56). These proteins are expressed at
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high levels in the placenta (26) and at lower levels in
trophoblastic tumors (46).
Despite the high sequence similarity of CEA and PSG,
they show differential expression patterns. PSG mRNAs are
found in the placenta, where no apparent expression of any
of the CEA gene subgroup mRNAs can be determined (48,
61). Colonic tumors, on the other hand, contain transcripts
for CEA and NCA but not PSGs (48, 60, 61). In addition,
differential expression of CEA and NCA mRNAs can be
found in various other tumors (7, 60). There is a notable
difference in the amounts of CEA protein found in normal
colonic mucosa compared with colonic tumors (8). Some
evidence has recently been presented which would suggest
that a rapid loss of CEA takes place in normal colonic
mucosa, but not in the corresponding tumors, and that the
rates of synthesis are comparable in both cases, which would
explain these differences (23). However, other results sug-
gest an increased transcriptional activity in colonic tumors
compared with the normal mucosa (7), which would also
suggest regulation of expression at the transcriptional level.
Indeed, differential methylation patterns could be shown to
correlate with the rate of CEA expression in various cell
lines (54). Recently, other factors have been reported to
exist which also play a role in the regulation of transcription
and translation of CEA-related genes (53).
As a basis for more detailed studies on the transcriptional
regulation of tissue-specific and developmental expression of
CEA, as well as its possible role during embryo and tumor
development, it is necessary to characterize the CEA gene.
In this paper, we report the isolation of a cosmid clone which
contains the complete transcriptional unit of the CEA gene,
including its promoter region. We have carried out restric-
tion endonuclease mapping and have determined the exon
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structure of this gene. Sequence and functional analyses of
the putative promoter regions of the CEA gene, together
with an NCA gene whose isolation we have described
elsewhere (51), have been carried out to locate their promot-
ers. Furthermore, we have identified a region which appar-
ently conveys tissue-specific expression of the CEA gene.
MATERIALS AND METHODS
Chemicals and oligonucleotides. Enzymes were purchased
from Boehringer Mannheim Biochemicals, Bethesda Re-
search Laboratories, Inc., and Pharmacia/LKB. Radiochem-
icals, RNasin, and Taq polymerase were from Amersham
Corp. and Du Pont, NEN Research Products. All other
chemicals were of analytical grade. Oligonucleotides were
synthesized by the phosphoramidite method on an Applied
Biosystems 308A DNA synthesizer and purified by following
the manufacturer's protocol, as described previously (20).
Bacterial strains and cloning vectors. All work with recom-
binant DNA was carried out in accordance with the German
and U.S. safety regulations. A human cosmid genomic
library inserted in the vector pHC79-2cos/tk (27) was ob-
tained as packaged cosmids from W. Lindenmaier, Gesell-
schaft fur Biotechnologische Forschung, Brunswick, Fed-
eral Republic of Germany, and transduced into Escherichia
coli ED8767 by combining 0.1 ml of 50 mM Tris hydrochlo-
ride (pH 7.5), 10 mM MgSO4, 0.1 ml of ED8767 in LB
medium (optical density at 600 nm = 2) and 0.1 ml of
packaged cosmids. After incubation for 30 min at 30°C the
suspension was diluted with 2 ml of LB medium, incubated
for 60 min at 37°C with shaking, and plated out. For
subcloning of the insert DNA fragments, either the Blue-
script phagemid (Stratagene Inc.) and pUC18/19 were used
in E. coli JM109 and RRlAM15, or M13mpl8/19 bacterio-
phage DNA was transfected and amplified in E. coli JM107.
Screening of the human genomic cosmid library. Recombi-
nant clones were grown on nitrocellulose (Schleicher &
Schuell, Inc.) in the presence of ampicillin (50 ,ug/ml) and
amplified after the addition of chloramphenicol (150 p,g/ml).
Colony hybridization with a CEA-specific, 32P-labeled, 408-
base-pair (bp) RsaI-PstI restriction endonuclease fragment
from the 3' untranslated region of a CEA cDNA clone
(pCEA3 [60]) was performed in the presence of 50% form-
amide, 6x SSPE (lx SSPE is 0.18 M NaCl, 10 mM
NaH2PO4 [pH 7.4], and 1 mM EDTA), 1x Denhardt solution
(0.02% each Ficoll, polyvinylpyrrolidone, and bovine serum
albumin), 0.05% sodium phosphate, and 100 ,ug of sheared,
denatured salmon sperm DNA per ml at 42°C. The final wash
was in 2x SSPE-0.5% sodium dodecyl sulfate at 65°C.
Positive clones were purified and, for identification of a
full-length CEA gene clone, were hybridized with a 32p_
labeled synthetic oligonucleotide (CEAL, 5'-AGCCTCTGC
CAGGGGATGCACCAT-3') corresponding to nucleotide
positions 1798 to 1821 of the leader region of the CEA gene
(see Fig. 2). The hybridization took place in 50% formamide-
1 M NaCl-1% sodium dodecyl sulfate-100 ,ug of sheared,
denatured salmon sperm DNA per ml-10% dextran sulfate at
30°C, and washing was carried out in 2x SSPE-1% sodium
dodecyl sulfate at 10°C below the calculated melting temper-
ature (24).
Restriction endonuclease mapping. The cosmid clone was
mapped by digestion with the restriction endonuclease
AatII, which has three recognition sites in the vector. A
32.6-kilobase-pair (kb) AatII fragment contains the whole of
the insert and flanking vector sequences (0.1 and 1 kb). This
fragment was then partially digested with different restric-
tion endonucleases (BamHI, Sall, SmaI, SstI, and XbaI),
separated by gel electrophoresis in 0.5% agarose overnight
at 1 V/cm (4WC), and transferred to GeneScreen Plus mem-
brane (Du Pont, NEN) prior to hybridization with an oligo-
nucleotide probe, whose complementary sequence is located
in the 0.1-kb flanking sequence (cosl, 5'-TAGGCGTAT
CACGAGGCCCTTTCG-3'). After stripping, the blot was
rehybridized with an oligonucleotide (cos2, 5'-GGCGATGC
TGTCGGAATGGACG-3') whose corresponding sequence
is located in the 1-kb flanking sequence. After autoradiogra-
phy, the linear arrangement of restriction sites in the partial
digests was determined from the fixed AatII sites. Uncer-
tainties arising from this method could be resolved by
isolation of selected DNA fragments, followed by digestion
with a second restriction endonuclease and by agarose gel
electrophoresis separation.
The N-terminal domain and 5' untranslated regions were
located by Southern blot analysis with the 547-bp PstI
fragment from pNCA1 (20) and the CEAL oligonucleotide
(see above) from the leader region of the CEA cDNA,
respectively, as probes. The exon/intron boundary-
containing fragments were located on Southern blots by
using oligonucleotide probes homologous to regions at the
beginning and end of each A and B immunoglobulin con-
stant-like domains. The cosCEAl DNA was digested with
various restriction endonucleases and transferred to Zeta-
probe membrane (Bio-Rad Laboratories) as suggested by the
manufacturer. The membranes were hybridized with the
various oligonucleotides in Sx SSC (lx SSC is 0.015 M
sodium citrate plus 0.15 M NaCl)-0.5% nonfat dry milk-
0.01% sodium dodecyl sulfate. The hybridization and wash
temperatures were calculated by the method of Wallace and
Miyada (55). The CEA 3' untranslated region was located by
using an approximately 450-bp RsaI-EcoRI cDNA fragment
downstream of the first Alu sequence (36).
Determination of DNA sequences. Subcloned restriction
endonuclease DNA fragments in phage M13mpl8/19,
pUC18/19, and Bluescript phagemid vectors were sequenced
as single- or double-stranded templates by the dideoxy-chain
termination method (40), with universal or internal oligonu-
cleotide primers and a kit from United States Biochemical
Corp. For comparison of the nucleotide and deduced amino
acid sequences, the computer program Align (M. Trippel and
R. Friedrich, unpublished data) was used. The DNA se-
quence data have been forwarded to GenBank and have
received the accession numbers M31966 to M31975.
Determination of the transcriptional starts of the CEA and
NCA genes. (i) Primer extension experiments. Gene-specific
oligonucleotides complementary to CEA and NCA mRNA
species were used to prime extension reactions. We synthe-
sized oligonucleotides from the leader region of the CEA
gene (CEAL, see above) and the 5' untranslated region of
the NCA gene (NCA5'; 5'-TCTCTGTCCACCTCTTTG
TAGAGGA-3', corresponding to positions -15 to -39 in
Fig. 5). For the annealing reaction, 5 to 10 ng of oligonucle-
otide labeled with 32P at the 5' end was mixed with 2.5 ,ug of
poly(A)+ RNA isolated from a colon tumor (59) in 10 ,ul of 5
mM sodium phosphate buffer (pH 7.0)-S5 mM EDTA. After a
5-min denaturation at 90°C, NaCl was added (final concen-
tration, 80mM), and hybridization took place at 50°C for 1 h.
After this time the mixtures were allowed to cool slowly to
room temperature. The hybridization mix was adjusted to
17.5 mM Tris hydrochloride (pH 8.3), 4.3 mM MgCl2, 1.75
mM dithiothreitol, 3.5 mM deoxyribonucleoside triphos-
phates, 1 ng of dactinomycin per ,ul, 2 U of RNasin per ,ul,
and 0.8 U of reverse transcriptase per,ul in a volume of 25 RI1
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FIG. 1. Restriction map of cosCEAL. The following restriction endonuclease sites have been mapped: BamHI (B), EcoRI (E), PstI (P),
Sall (Sa), SmaI (Sm), SstI (S), XbaI (X), and degenerate MspI cloning sites [(M)]. Symbols: _, exons 5/L through 3'; OII, "NCA"3' (this
exon has been only provisionally characterized; see text). The exon names shown above the map are explained in the text.
and incubated at 42°C for 1 h. Following phenol extraction
and ethanol precipitation, the extension products were de-
natured and loaded onto a 6% polyacrylamide-7 M urea
DNA sequencing gel.
(ii) Si nuclease analyses. The transcriptional starts of CEA
and NCA were independently determined by Si nuclease
mapping. For CEA, a 1.6-kb PstI restriction endonuclease
fragment from cosCEA1, containing the first exon of the
CEA gene (Fig. 1), and for NCA a 606-bp PstI fragment from
clone lambda 39.2 (51), containing the first exon of the NCA
gene, were cloned into M13mpl8. Gene-specific, single-
stranded DNA fragments which were complementary to
their mRNAs were synthesized by using the same oligonu-
cleotides as for the primer extension experiments (see
above). For this, the oligonucleotides were 5' end labeled
with polynucleotide kinase and annealed to the single-
stranded M13 subclones by the Perkin Elmer Cetus
GeneAmp DNA amplification protocol, followed by exten-
sion with Taq polymerase at 72°C for 30 min. The resulting
double-stranded products were digested with SmaI (for
CEA) or PstI (for NCA), and the single-stranded 456nc
CEA-specific fragments and the 562nc NCA-specific frag-
ments were separated on a preparative 4% polyacrylamide-7
M urea gel and extracted by electroelution. Hybridization
with poly(A)+ RNA from a colonic tumor (see above) and Si
nuclease mapping were performed essentially as described
by Maniatis et al. (29). For digestion of single strands, the
DNA-RNA complexes were incubated with 1,000 U of S1
nuclease per ml for 30 min at 18°C and analyzed as above.
Construction of promoter-CAT gene hybrids. The 3.4-kb
SstI-EcoRI fragment of the cosmid clone cosCEAl (Fig. 1),
which contains the first two exons of the CEA gene, was
digested with NcoI. The 835-bp NcoI fragment was isolated
and treated with Si nuclease to generate blunt ends, result-
ing in an 831-bp DNA fragment located at nucleotide posi-
tions -832 to -2 with respect to the translational start of the
CEA gene. The vector pBLCAT3 (28), which contains the
promoterless bacterial chloramphenicol acetyltransferase
(CAT) gene was linearized by using BamHI. The ends were
filled in with the Klenow fragment of E. coli DNA polymer-
ase I, and the blunt-ended NcoI fragment was inserted to
generate the constructs pCEA832/2CAT and pCEA2/
832CAT (see Fig. 6). A 409-bp PstI-BstXI fragment was
removed from clone pCEA832/2CAT, and after generation
of blunt ends with T4 DNA polymerase, the rest was
religated, resulting in the construct pCEA424/2CAT (see
Fig. 6). In parallel, a 420-bp HindIII-BstXI fragment of
plasmid pCEA832/2CAT was removed, and the rest was
ligated to a 2.9-kb HindIII-BstXI fragment from the 5' end of
cosCEAl (Fig. 1), generating the construct pCEA3300/
2CAT (see Fig. 6).
The 2.7-kb EcoRI fragment from the genomic NCA clone
lambda 39.2 (51), which contains the first and second exons
of the NCA gene, was subcloned into pUC18. This was
digested with SstI, which cuts in the polylinker of pUC18
and internally, generating a fragment containing the 5' un-
translated region of the NCA gene, extending from nucleo-
tide positions -48 to -1246 with respect to the translational
start (see Fig. 5). This was treated with T4 DNA polymerase
to generate blunt ends and inserted into the above-men-
tioned, blunt-ended pBLCAT3 vector. Clones were con-
structed containing the inserts in both orientations
(pNCA1246/48CAT and pNCA48/1246CAT; see Fig. 6). The
construct pNCA1246/48CAT was digested with PstI, the
663-bp fragment from the 5' region of the insert was re-
moved, and the rest was religated, resulting in the construct
pNCA583/48CAT (see Fig. 6). A 299-bp Hindlll fragment
containing vector sequences and the 5' portion of the insert
from clone pNCA583/48CAT was removed. Religation of the
rest generated the construct pNCA284/48CAT (see Fig. 6).
Cells and transfection. The colon adenocarcinoma cell line
SW403 (25) was grown in RPMI 1640 medium supplemented
with 10% fetal calf serum. HeLa cells were cultivated in
Dulbecco modified Eagle medium containing 10% fetal calf
serum. Cells were plated at a density of 106 per 6-cm dish 24
h before transfection. The transfections were carried out by
lipofection with 20 ,ul of Lipofectin (Bethesda Research
Laboratories) and 7 ,ug of pSV2CAT (14) DNA or equimolar
amounts of the promoter-CAT gene constructs in 3 ml of cell
medium without serum, modified as described by Felgner et
al. (12). These parameters were optimized for both cell lines.
The cells were incubated for 15 h, and then 3 ml of medium
plus 10% fetal calf serum was added; 24 h later the medium
was replaced with fresh medium. After a further 24 h of
incubation, the cells were harvested in phosphate-buffered
saline-1 mM EDTA without bivalent cations, by using a
rubber policeman.
CAT assay. Pelleted cells were suspended in 75 ,ul of 250
mM Tris hydrochloride (pH 7.5), and cell extracts were
made by three freeze-thaw cycles. Thereafter, the cells were
spun down for 10 min at 13,000 x g and 4°C. The superna-
tants were incubated for 10 min at 65°C, and the CAT
activity of the cell extracts was analyzed as described
previously (14). The assay mixture contained (in a final
volume of 100 ,u) 30 RI of cell extract, 20 ,ul of 8 mM
chloramphenicol, 20 ,ul of 0.5 mM [14C]acetyl coenzyme A
(7.4 kBq), and 30 RI of 250 mM Tris hydrochloride (pH 7.5)
and was incubated for 1 h at 37°C. After two extractions with
100 RI of ice-cold ethyl acetate to separate the radio labeled
acetyl coenzyme A, half of the organic phase containing
radiolabeled acetylated chloramphenicol was analyzed by
liquid scintillation counting in Aquasol (Du Pont, NEN).
RESULTS
Isolation and characterization of cosCEAl. A CEA-specific
cDNA restriction endonuclease fragment from the 3' un-
translated region (see Materials and Methods) was used to
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probe 340,000 cosmid clones from a human genomic library.
Three positive clones were isolated whose restriction endo-
nuclease and hybridization patterns with CEA cDNA and
oligonucleotide probes from different regions of the gene
revealed them to be identical (data not shown). Closer
analysis of this clone (cosCEA1) by restriction endonuclease
mapping (Fig. 1) and DNA sequence analysis (Fig. 2) re-
vealed that the 31.5-kb insert contains 11 exons, 10 of which
represent the complete sequence for the CEA mRNA. The
first exon contains the 5' untranslated region (see below) and
part of the leader domain (5'/L exon). The second exon
encodes the rest of the leader and the complete N-terminal
(immunoglobulin variable-like) domain (L/N exon). The fol-
lowing six exons encode immunoglobulin constant-like half
repeats (A and B exons), revealing a strong correlation
between the exon and domain borders. A closer analysis of
the derived amino acid sequences shows that the immuno-
globulin-like domains, which contain a predicted, highly
ordered arrangement of P-sheets, are always surrounded by
proline-rich regions in CEA. These regions would disrupt
ordered structures, thus marking the boundaries between
adjacent domains. Such proline-rich regions are located
close to the exon borders (Fig. 3). The B3 exon is followed
by two further exons: the first contains the hydrophobic
membrane domain and part of the 3' untranslated region
(M/3' exon), and the next contains the rest of the CEA
3'-untranslated region (3' exon).
Determination of the transcriptional starts of the CEA and
an NCA gene. As a basis for closer studies regarding the
regulation of transcription of the CEA gene, we have deter-
mined its transcriptional start through primer extension (Fig.
4A) and S1 nuclease analyses (Fig. 4B). In both assays, a
tight cluster of transcriptional start sites was located 104 to
110 nucleotides upstream from the translational start of the
CEA gene (Fig. 4). The primer extension assay indicates
transcriptional start positions which are 2 or 3 nucleotides
shorter than those determined by the Si nuclease assay. This
difference is probably due to premature termination of the
reverse transcriptase in the former assay, presumably be-
cause of steric interference by the cap structure, as reported
elsewhere for a different gene (18). The location of the
transcriptional start site cluster is comparable to that found
by Beauchemin et al. (4) for the CEA mRNA. These authors,
using only the primer extension analysis determined the
transcriptional start to be 102 nucleotides upstream from the
translational start.
We have also mapped the transcriptional start for an NCA
gene, whose isolation we reported elsewhere (51), by using
primer extension and Si nuclease analyses (Fig. 4). It could
be shown that this gene also has a cluster of transcriptional
start sites at a similar position to that found for the CEA gene
(between nucleotide positions -102 and -112, relative to the
translational start).
Sequence comparison of the putative promoter regions with
other CEA-related genes. We have sequenced the region
around and upstream from the first exon of the NCA
genomic clone (Fig. 5). The putative promoter and upstream
region of a third gene, CGM1, which was published recently
(50), is compared with the NCA sequence in Fig. 5. It is
obvious that NCA and CGM1 are homologous over the
whole region that was compared. Although no transcripts
have so far been identified for the CGM1 gene, this homol-
ogy indicates that we may expect a similar expression
pattern as for NCA, assuming that this gene is active. In
comparison, the CEA gene reveals homology in a region up
to approximately 500 nucleotides upstream of the initiator
codon, but no homology could be determined farther up-
stream by dot matrix analyses (data not shown).
No canonical TATA or CAAT boxes could be identified at
the expected positions (10) upstream of the transcription
initiation sites of the CEA or NCA genes. A TATA se-
quence, which was also described elsewhere (35), can be
found approximately 130 nucleotides upstream from the
transcriptional start of the NCA gene. However, this dis-
tance would appear to be too large to have functional
importance, because in most eucaryotic genes TATA se-
quences are almost always located 25 to 30 bp upstream from
the initiation site, except in yeasts, for which distances of up
to 120 bp have been described (reviewed in reference 44).
Indeed, this putative TATA box is missing in the CEA gene
at the corresponding position (Fig. 5), although 2 nucleotides
downstream a degenerate TATA sequence can be found
(TAGAA).
Analyses of the CEA and NCA gene promoters through
transient-transfection assays. To determine the exact loca-
tions of the CEA and NCA gene promoters, it was necessary
to use a cell line in which the CEA and NCA genes are
transcriptionally active. We chose the CEA-producing hu-
man adenocarcinoma cell line SW403 (25, 59) and, as a
negative control, HeLa cells (59). Northern (RNA) blot
analysis revealed transcripts for both CEA and NCA in
SW403 cells, but not in HeLa cells (59; data not shown).
Various restriction endonuclease fragments, containing up
to 3,300 bp of the region upstream from the translational
start of the CEA gene, or up to 1,246 bp of the region
upstream of the NCA gene translational start, were attached
to the bacterial CAT reporter gene. The activities of the
various promoter constructs were tested in SW403 and
HeLa cells. The relative strengths of the promoter fragments
were determined by quantification of the CAT enzyme
activity. For comparison, plasmid pSV2CAT, which con-
tains the simian virus 40 early promoter in front of the CAT
gene, was transfected into each cell line and CAT activity
levels were measured. By using the assumption that the
simian virus 40 promoter is equally active in both cell lines,
the values obtained for each of the CEA and NCA promoter
constructs were expressed as a percentage of the values
obtained with pSV2CAT. All of the CEA and NCA con-
structs were active in their correct orientations, in both cell
lines (Fig. 6). Apart from the pNCA1246/48CAT construct,
for which the activity in HeLa cells was slightly higher than
in SW403 cells, the other NCA constructs showed similar
FIG. 2. Nucleotide sequence of cosCEAL. Intron and exon nucleotides are shown in lowercase and capital letters, respectively. The exon
boundaries are marked with arrows over the nucleotide sequences. Restriction endonuclease sites used in subcloning fragments for
sequencing are indicated. Polyadenylation sites are underlined. The poly(dA-dC) sequence is heavily underlined. Alu-type repetitive
sequences are underlined with dotted lines. The approximate size of nonsequenced regions are shown in brackets and are taken into account
for the numbering system (indicated in the margin by an asterisk). The exons were sequenced through the exon/intron boundaries (ca. 100
nucleotides) to confirm identity with the published cDNA sequence of Oikawa et al. (36). In no cases were any substitutions found. A
polypurine sequence was noted at the beginning of the gene (1516 to 1588).
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gagLtcctca cacggactct gtcagctcct ccc, a!gcc tatoggccgc ccacctqagg cttqtogjcc gcccacttga ggcctgtogg ctgccct= 100
agqcagctc ctgtccccta caccccctcc ttcccxgggc tcagctgaaa gggcgtCtcc cagggcagct ccctgtgatc tccaggacag ctcagtctct 200
cacaggctcc gacgccccct atgctgtcac ctcacagccc tgtcattacc attaactcct cagtcccatg aagttcactg agcgcctgtc tccOggttac 300
aggaaaactc tgtgacaggg accacgtctg tcctgctctc tgtggaatcc cagggcccag ccagtgcctg acacggaaca gatgctccat aaatactggt 400
taaatgtgtg ggagatctct aaaaagaaac atatcacctc ogtgtggccc ccagcagtca gagtctgttc catgtggaca caggggcact ggcaccagca 500
tgggaggagg ccagcaagtg cccgcggctg ccccaggaat gaggcctcaa cccccagagc ttcagaaggg aggacagagg cAg4ga atagatcctc 600
cgocctgacc Zg=agccta atcctgagtt cagggtcagc tcacaccaog togaccctcg tcagcatccc tagggcagtt ccagacaagg ccggaggtct 700
cctcttgccc tccagggggt gacattgcac acagacatca ctcaggaaac ggattcccct ggacaggaac ctggctttgc taaggaagtg gaggtggagc 800
ctggtttcca tcccttgctc caacagaccc ttctgatctc tCccacatac ctgctctgtt cctttctggg tcctctgagg acctgttctg ccaggggtcc 900
ctgtgcaact ccagactccc tcctggtacc accatgggga aggtggggtg atcacaggac agtcagcctc gcagagacag agaccaccca ggactgtcag 1000
ggagaacatg gacaggccct gagccgcagc tcagccaaca gacacggaga ggagggtcc ccctggagcc ttccccaagg acagcagagc ccagagtcac 1100
ccacctccct ccaccacagt cctctctttc caggacacac aagacacctc cccctccaca tgcaggatct ggggactcct gagacctctg ggcctgggtc 1200
tccatccctg ggtcagtggc ggggttggtg gtactggaga cagagggctg gtccctcccc agccaccacc cagtgagcct ttttctagcc cccagagcca 1300
cctctgtcac cttcctgttg ggcatcatcc caccttccca gagccctgga gagcatgggg agacccggga cctgctgggt ttctctgtca caaaggaaaa 1400
taatccccct ggtgtgacag acccaaggac agaacacagc agaggtcagc actggggaaa gacaggttgt ccacagggga tgggggtcca tccaccttgc 1500
ogaaaagatt tgtctgagga actgaaaata gaagggaaaa aagaggaggg acaaaagagg cagaaatgag aggggagggg acagaggaca cctgaataaa 1600
r- 5'UT
gaccacaccc atgacccacg tgatgctgag aagtactcct gccctaggaa gagactcaGG GCAGAGGGAG GAAGGACAGC AGAXYAGACA GTCACAGCAG 1700
(CCAAA ACrGJIxGG APMrkAA CFCIxTCA CiGCGGAi CA GAGCA AG fACAGACAT GSAGTrc TUxGxx: COCAAGAG 1800
Ib tGluSerPro SerAlaProP roHisArgTr
GI CATO= TXCA Tu[CIGCC AGgtgaaggg aggacaaccc ctgggagagg gtgggaggag ggagcacaga gactggctgg ggtctcctgg 1900
pCysIlePro TrpGlnArgL euLeuIeuTh rA
gtaggacagg gctgtgagac ggacagaggg ctcctgttgg agcctgaata gggaagagga catcagagag ggacaggagt cacaccagaa aaatcaaatt 2000
gaactggaat tggaaagggg caggaaaacc tcaagagttc tattttccta gttaattgtc actggccact acgtttttaa aaatcataat aactgcatca 2100
gatgacactt taaataaaaa cataaccagg gcatgaaaca ctgtcctcat ccgcctaccg cggacattgg aaaataagcc ccaggctgtg gagggccctg 2200
ggaaccctca tgaactcatc cacaggaatc tgcagcctgt cccaggcact gggtgcaacc aagatcacac aaatccctgc cctcatgaag ctcatgctct 2300
catggggagg aagacagaca tacaaagaga tctagaatgt gaggtcaggt gttgacaaga gcctggaggg aatagagcag ggaaaggtca gaaaaggaag 2400
acccaaggtc tctagaggag gtgtcaggga agggatctcc caagaatgcc ctgatgtgag caggacctga aggcaatggg gagggagcog tgaagacccc 2500
tggaaaagca gattccacac agggaaatgc caaggtcgga ggtgctaagg aaataggaga cacactgctg accttgacct agtaggacac acacacacac 2600
acacacacac actcactcac tccagggctg ggggatgaag agacctgctc aggacccagg accccatttt tccaccctaa tgcataggtc ccaatattga 2700
f - -Wde de
ccgatgctct ctgctctctc ctagCCTCAC TTCI TT CGGAXG CCCACCACTG CCAAGCTAC TATIGAA ACGCXXXXA ATGTSCA 2800
laSerL euLeuThrPh eTrpAsnPro ProThrThrA laLysleuTh rIleGluSer ThrProPheA snValAlaGl
GGGGAGGAG GiuCTACE T'GI4IATCTSCCAGAItTI TG(CCTG GTACAAAGGT GAAAGAGIGG ATGGAACX TXAACMTTATA 2900
uGlyLysGlu ValLeuLeuL euVaiHisAs nLeuProGln HisLeuPheG lyTyrSerTr pTyrLysGly GluArgVaLA spGlyAsnAr gGlnIleIle
GGATATGTAA TAGGAACIA ACAACTAC CCAGOG CATAAGTGG TCGAGAGATA ATATAXOCCA AMGCATCOCT GCTIXCAG AAGAlCAI 3000
GlyTyrValI leGlyrhrGl nGlMThr PreGlyPrcA laTyrSerGl yArc1uIle IleTyrProA snAlaSerLe uleuIleGln AsnIleIleG
g--..Iti 2
AGAAIGPAGC AG GATTU ASC=PAC TCATAAAGIC AGAIClTJG AATGAAGAAG CAAZCAGF]XXA XXTA TtCCgtgagt gattccccca 3100
lnAsnAspT rGlyPheTyr ThrleuHisV alIleLysSe rAspLeuVal AsnGluGluA laThrGlyl nPheArgVal TyrP
tgacctctgg gtgttggggg tcagttctac ttcccacaca caggattatc aggcctgggc tgtgctgtgg ccccctctgc attacgaacc atgttagggt 3200
ZOO1 Pst.
ttgggcattt agtgcaggat acacacagaa gagacaaact tcaacagatc aga.ttCctt tccggcatcc agaccatgc S.l (ca 4.6kb) ... 7900*
tgttccagat catogtgcat ctgtcttgtg acacatgcac ccaccgtggg xtttttaagg gctcaggtgg gctgagaggt ggaaggtgcc aactctgatt 8000
i-Al dbnin
gaaagatgcc tgtgaggaat caaaggtxca cacagggxaa tcttctctct gttatctgca agMCAGCTG aCAAGOZCT CA1CIWAG CACAACI 8100
roGluLeu ProLysProS erIleSerSe rAsnAsnSer
AAaCrGT AGGCAAGGT Z TACrGTG AACTGAGAC 2CAGCbCGA ACCTACCx'r GGXTAAA CAATCAGACQ P 8200
LysProValG luAspLysAs pAlaValAla PbeThrCysG luProGluTh rGlnAspAla ThrTyrLeuT rpTrpVaLAs nAsnGlnSer LeuProValS
GICCAGCT GCAGCTZ AAGCAAA GGCiXC1tAC CTATICAAT GICACIAAGA AJACACAIGP AAGCTACAAA 1ISGAAIA AGAACOXAGr 8300
erProArgIe uGlnLeuSer AsnGlyAsnA rgThrLeuTh rLeuPhAsn ValThrArgA snAspThrAl aSerTyrLys CysGiuThrG lnAsnProVa
I -Inktrc 3
GAGTIXCAGG CGCAGIGAIT CAGTCAICCT GAAITSTOCC Tgtgagtata tctgctcctc tctggcccag gctgccagcc aaatccacag ggecagaxxg 8400
lSerAlaArg ArgSerAspS erValIleLe uAsnValLeu T
ggatttctca gtccctctca ggttcaagta cacagaccct caacxctgga catcxagact gtctgtgact ttctgcccag aaaa.... (ca 0.4 kb).. 8900*
main
ttagagggac actgtggtcc ttccatagac caggaacttc cacttccctc tgacaatatc acctgtggct ttattttgtt tgctccagAT GCXXXX;ADG 9000
yr GlyPrcAspAQOCCCPACAT ¶f AAC.ACAIC ACAPC AK GGAAAACTGAMA JTCTCT GCCAXGCAGC CXAACCAA CCTGCACAGr ACITTGr 9100
laProThrIl eSerProleu AsnThrSerT yrArgSerGl yGluAsnLeu AsnLeuSerC ysHisAlaAl aSerAsnPro ProAlaGlnT yrSerTrpPh
TGTCAATc-GG ANTTICAG AAITCA AGCTrT ATXCCCAA TCACWGIGAA TMATNGGA 2C ATA=GT GOCAAGCA TAACIrAGAG 9200
eValAsnGly ThrPhGlnG lnSerThrGl nGluLeuPhe IleProAsnI leThrValAs nAsnSerGly SerTyrmirC ysGlnAlaHi sAsnSerAsp
r-- Irn 4
PCTGGOCTCA AM lGAC AGIAGcATPG AAT AE G ATG;gtaagtg gatccaogaa gcactgacat catgttttga ggtggagtct gtctggtttt 9300
ThrGlyLeuA srArgThrTh rValThrThr IleThrValT yrA
caaacaagag ccaggaagac attttctatc ccagcctgtg tccagtgggc acaagcaaat cccagattct cccactgaac ctccccaata tgtctctaca 9400
gactcttttc ttcttgttct gatttctcat gcggcccc aggccagctt ggaatgtggg gcggaggctc cctcagcccc acagccctgt gtagtggagg 9500
aag............ . .. ......... ..... (ca 1.6 kb) ..... .......... .............. .. .......... .......... 11,100*
aggtctctga gccctcagat cattgtgcat ctgtcttgtg acgcacacac acctgccatg agcttttaax gactcagttg ggctgagagg tgggagatgc 11,200
r-A2 ck-min
caactctqat tqatagatgc ccgtggagga atcacaggtg ccacacaggg caatcttctc tctgTtatct gcacagCAGAcXjcoVA C(XCCIrAA 11,300laGl uProProLys ProPheileT
CAGAA CmCACOC GTGGAGGAT AGGAITGT AGCCTTAC TGTGAACG AcXTITcM CACAAMArC C=TGlGTG TMTMTAA 11,400
hrSerAsnAs nSerAsnPro ValG1uAs luAspAlaVa lAlaLeuThr CysGluProG 1uI1eGlnAs nThrIfrPyr LQuTrpTrpV aLAsnAsrn1
GCCICCCG G.AG1XCXCGC:AT GIICAAIGAC AMAX-GC TCACIACT CA=GTICACA AGGAATGATG TAZGXCXA TAGtGA 11,500
nSerLeuPro ValSerPraA rgLeuGln1) uSerAsnAsp AsnArgThrL euThrLeule uSerValThr ArgAsnAspV alGlyProTy rGluCysGly
A AATTAAG= TGACCAPAGC COCAGXTCA IWCIGAIAT CZjTgtgag tatcttctgt tcctctgtgg ctcaggctcg gagcccaaat 11,600
IleGlnAsnG luLeuSerVa lAspHisSer AspProValI leLeuAsnVa lLeuT
ccacatagcc aaagt ..... ........ ....... (ca 0.5 kb) .... ..................... ...... . ........ .......... 12,100*
-B24mm1n
agggxacac tgttgccctt tcacagacca ggagcttccc ctttgctctg atgacattca cctgtggccc tattctcttt gctccagATG GCCCAGAOA 12,200
yrG lyPraAspAs
OXCCAAT T DIC AT ACATATA CCGICAG G AOICIA GCIC= A TCrAAC CTICAArII'cI 12,300
pProThrIle SerProSerT yrThxTyrTy rArgProGly VaLAsnLeuS erLeuSerCy sHisAlaAla SerAsnProP rcalaG1nTy rSerTrpLeu
A lXGG ACAWCCAGCA AACACAA GAGCIrFIA TCTCIAACAT CACIG5GG ACAGCGGAC ¶ECTACCTG CCAGGOCAMT AACT IA 12,400
IleAspGlyA snIleGlnGl nHisThrGln GluLeuPheI leSerAsnIl eThrGluLys AsnSerGlyL euryrThrCy sGlnAlaAsn AsnSerAlaS
g Ii ~6
ci3ACG CAGGCACA GGMGACAA TCACAGTC hGgtaagtgg atccctggac cgttagcaat atgttctgga gcggaatctg tctggttttc 12,500
erGlyHisSe rrgThr ValLysThrI leThrValSe rA
agaaaagagc caggaagaaa ttttctttcc tagtatgcat ccaatgggca caagcaatcc caaattcaat cctgagcact cccaatttgt ctctacaaac 12,600
actctt .... .......... ....... ....... (ca 1.6 kb) ... ........... .. .. . ... ...... .................... 14,200*
aagzagccgg ccttacagtc tctgagccct cagatcatcg tacatctgtc ttgtgataca cacacctgcc atgggctttt aaggactog gtgggctgaa 14,300
r- A3 AIn
gggtgggagt tgccaactct gattgaaaga tgcctgtgag gaatcaaaag tgccacacag ggcaatcttc tctctgttat ctgcacagCG GAGCTGCXA 14,400
la GluLeuProL
AGO=CAT CWCAZAPC AACICCAAAC CCTIGGAGGA CAAGGA=T GIG3CX:A XCIGIGMXA( I¶AIOGG AA PCAACCT AMIGTGGGIT 14,500
ysProSerIl eSerSerAsn AsnSerLysP roValGluAs pLysAspAla ValAlaPheT hrCysGluPr cGluAlaGln AsnThrThrT yrLeuTrpTr
SGTAMTGGT CAGGOCTCC CAGTAZX: CAGGTGCAG CI XMAA3 GZAACAGXC Cr7Z.C¶ICTI TGTI-A CAAGAAAIG CGCAAGAGCC 14, 600
pValAsnGly GlnSerLeuP roValSerPr oArgLeuGln leuSerAsnG lyAsnArgTh rleuThrLeu PheAsnValT hrArgAsnAs pAlaArgAla
i - Irt. 7
TATGTAIGIG GAACPGAA C7:AGIAGT GCAAAMXZA GITGA=GT CACICTAT UXuIC'Igtg agtatctctg ttcctctgtg gccctggttt 14,700
TyrValCysG lyIleGlnAs nSerValSer AlaAsnArgS erAspProVa lThrLeuAsp ValleuT
........... . . . . .......... ....... (ca 1.8 kb) ... ........... .. .. . .. ...... .................... 16,500*
atttggactt tttaacacag xattgggaca gxattcagag gxacactgtg gcxxttctac aatcaggagc ttcccctttc ctctgatgac atcacctgtg 16,600
gctttgttct ctttgttcca gATGXXCXfG ACAOCXCXAT CATTI'CCKXC OCAGAM CiTAD1TC GGGACGAC CIUDXICT CCTGCCACTmc 16,700
yrGlyPrcA spThrProIl eIleSerPro PrcAspSerS erTyrLeuSe rGlyAlaAsn LeuAsnLeuS erCysHisSe
GO 1TAAC CCA¶TXCCXC AGcrA IC GQAICAAT GPGATACCSC AGCAACPCAC PCAAGI1X= TAITCA AAATICAGCC AMTAATAAC 16,800
rAlaSerAsn ProSerPrcG lnTyrSerTr pArgIleAsn GlyIleProG lnGlnHisTh rGlnValLeu PheIleAlaL ysIleThrPr oAsnAsnAsn
g- Ints 8
GSGCTAIG UCTGr CECTAIFIG GCrACTGGCC GCAATAATTC CATAGICAPG AGCATAG ICICISgtaa gtgctccct ggagcatcag 16,900
GlyThrIyrA laCysPIhVa lSerAsnLeu AlaThrGlyA rgAsnAsnSe rIleValLys SerIleThrV alSerA
N=l
catcatattc tggggtggag tctatctggt tctcaccaaa gagccaagaa gacattttct ttcccagtct gtgttccatg _3gcacaagga aatcccaaat 17,000
tctatcctga gcxccctcac . (ca 4.8 kb)...... 21,800*
tccatgacgg aogattcagC ATC¶W3ACTlT l=GGIC ICTACTGG G (MAM= GOCATA2XA IllGlCGGCT G XXXIT GC=I TAT 21,900
1 aSerGlyIhr SerPraGlyL euSerAlaGl yAlaThrVal GlyIleMstI leGlyValLe uValGlyVal AlaLeuIle*
I *.rmx 9 Pst3
ACAGCICT G IIAGTI':CATTITZG GRAAGATGgt agt.ataatg gcctttcctc ttgttctgtt tcccag.. (ca 2.0 kb).24,000*
** . 3'1=
aattatcatc agatttttaa ctgtactcat tttaaatctt gtcattcaca gACAGrITT TT CTAAAGCAT ICCAGC TA:PGIM 24,100
AAMIIPTT1AOAAGGA TTf A 24,200
...i i.. ; .. ..rm.. .a.A(~.~ 24, 300
M022L&--MOXM--Q&MXQ-ACWaAGCW--ACrOCAI=--AAAAAGAAAA--GAAAAGAAC.A-MZl8¶[ T_CICIIGAA TACAAGTTC 24,400¶ATACCACT GCACTMI ACAULTXA AAACTIAAT GAAC IASZCrfIAT GAAACrXCA CMGACAA GCAGAAAA TAAJTAAMI 24,500
CA¶IGACTA AAAACTAA TGAGGATAAT ATrIrIATAA 'ITITITAT GAATTI'( hGATICITIA, AAMMT= TICCAGA-T hccuAkCT 24,600
lTITItTIT TAAGCTAI ACAPGCTCA GCAATTGATA AAATATACIT TIGA A ATAWGPC ATITMATIT TCTlCT GGICGCIA 24,700
Poly A
GACIIGGAA ACTICATG AATAITTATA TI;ATTAM ATTAGITAT IGCACAAGTT C,ZAAT UGCICIIG TATGPCAGAA TPCAITIGA 24,800
Poly A
AACAIGC3IT ATA1TANXZAA GACTIGlCT A ¶EXAATGT= ATIGAGPAT ATAAPCAT NX3GTAAIA& O£C?CAX CIPCACMA AGICIGMGT 24,900
Ain p
CAGCCrTGGT TIGXTtlXlr AGICIcAAT AAACFICTAA AAPGTTAAC TG4GAlT TATAWACT WCCAGCAAG CAACITAA A& ID;jM 25,000
..P ..-..m...............2-A. ..... (ca 180 bp Alu repeat) .25,200*
GICTAAIAGG TCACICCTA CICiIGTG 25, 300
Poly A
CAGTTATGAA AAAIGRA CCAAfGPT MC ETA'IATITAACA ITrMIz TT ATTIG GrAGATAG ACAJXX T 25,400
GCLGAM TAIGIAAA AAAACTATA GTACACTGT TAEAlCIG TCACTITA CAFISAGc *l-ITIATTAT CCAOCIGTAG ACrACAGTGG 25,500
AOO:
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- 1 Leader -22 1 N-terminal Domain
MESPSAPPHPIPW2RIILTASITFWNPPTTA KLTIESTP ......
108 Al 201 Bi
EATGOFRVY)ELPKPS ...............VILNVLYGPDAP .....
285 A2 379 B2
TTVITITVYAEPPKPF...............VILNVLYGPDDP.
464 A3 557 B3
T ITVSAEIPKPS ............... LVTVYCPDTPI ....
642 M-domain 668
SIVKSI SGTSPGLSAGAIVGIMIGVLVGVALI
FIG. 3. Correlation of exons with protein domains in CEA. The
amino acid sequence, including the leader and membrane peptides,
is shown in single-letter code over the regions of exon/intron
boundaries. The amino acids whose codons are split by exon/intron
junctions are shown in outline. The N-terminal leader peptide is split
at codon -22, a common feature in immunoglobulin-related genes.
The N terminus of the mature protein is lysine (K). Each of the
immunoglobulin-like domains (N-terminal, Al, Bi, A2, B2, A3, B3)
ends with a predicted ,B-strand (underlined) and begins (except for
the N-terminal domain) with a predicted interconnecting loop, rich
in proline residues (bold). The membrane peptide (M-domain),
which serves as a signal for attachment of the phosphatidylinositol
glycan moiety, is at the beginning of a separate exon.
activity in both cell lines. These values ranged from 4 to 20%
of the pSV2CAT activity. The CEA constructs, however,
exhibited a much higher CAT expression in the SW403 cells,
in which the mean value was approximately 110% for the
pCEA424/2CAT construct, compared with the HeLa cells,
in which the values ranged from 5 to 12% of the pSV2CAT
activity for all CEA constructs. The expression levels of the
longer CEA constructs (pCEA832/2CAT and pCEA3300/
2CAT) were also elevated in SW403 cells compared with
HeLa cells (50 and 40% of the pSV2CAT activity, respec-
tively). The constructs for both genes in which the promot-
ers were in the inverse orientation (pNCA48/1246CAT and
pCEA2/832CAT) showed no promoter activity (<1%) in
either cell line. The pBLCAT3 vector, which lacks a pro-
moter entirely, was also not active (<1%).
DISCUSSION
We have isolated a cosmid clone (cosCEAl) from a human
genomic library; this clone contains the complete coding
sequence for CEA, as determined by restriction endonucle-
ase mapping and DNA sequencing (Fig. 1 and 2). Another
group recently reported the independent isolation and char-
acterization of an identical clone from the same genomic
library (T. C. Willcocks and I. W. Craig, Abstr. XVIIth
Meet. Int. Soc. Oncodevel. Biol. Med. 1989, abstr. no. 1P-1,
p. 51). The exon structure is the same as that reported for
other members of the CEA gene family for the immunoglob-
ulin variable- and constant-like domains (33-35, 50, 51) and,
likewise, for other members of the immunoglobulin super-
gene family (58). All of the immunoglobulin-like domain
exon sequences reported here are present in the mature CEA
mRNA, whose sequence has been determined elsewhere (2,
4, 36, 59). Hybridization studies with restriction endonucle-
ase fragments from the N-terminal and repeat domains of a
CEA cDNA do not indicate the existence of additional
immunoglobulin variable- or constant-like domain exons in
the CEA gene.
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FIG. 4. Determination of the transcriptional starts of the NCA
and CEA genes through primer extension (A) and S1 nuclease (B)
analyses. As length markers, DNA sequences of the corresponding
genomic regions, with the same NCA (A) or NCA and CEA (B)
oligonucleotide primers for each gene as for the transcriptional start
analyses (NCA5' and CEAL, respectively), were used to allow the
start positions to be determined exactly. In both cases, the numbers
indicate the transcriptional start sites with respect to the initiation
codons of each gene.
Analysis of the 3' end of the gene has revealed that the
hydrophobic membrane domain is encoded by a separate
exon (M/3'), which also contains the first 39 nucleotides of
the 3' untranslated region (Fig. 1 and 2). This region is
homologous to a corresponding section of the 3' untranslated
region found in NCA cDNA sequences (2, 31, 47). After this,
the sequences of the 3' untranslated regions of the CEA and
NCA mRNAs are no longer homologous. The point of their
divergence correlates exactly with the end of this M/3' exon
in the CEA gene (Fig. 2). The following exon in the CEA
gene contains the rest of the CEA 3' untranslated region
(Fig. 1 and 2, 3' exon). Preliminary characterization of the
region directly downstream from this exon has revealed a
sequence which shows homology to the NCA 3' untranslated
region ("NCA" 3' exon), including a conserved EcoRI
restriction endonuclease site (Fig. 2; data not shown). A
consensus intron acceptor site (30) exists at the 5' end of this
NCA-like exon (Fig. 2), which correlates with a correspond-
ing splice site in a related PSG gene (33). This PSG gene also
contains both CEA and NCA-like 3' untranslated regions,
thus confirming the model, originally proposed by Oikawa et
al. (33) and extended by Zimmermann et al. (61), that all
genes belonging to the CEA family contain such a complex
3' unit. Therefore, variability in the 3' untranslated regions
in the CEA and NCA mRNAs is probably due to differential
splicing of their corresponding genes. These results also
indicate that a CEA transcript which contains the NCA-like
3' untranslated region could exist and that the probe from the
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MCA -1246 GAATTCCACAGCAATAAACACAATGATAACCATCACGTACTCAACACCCGCCTGGCcACTC GCcTCCCACA TATTCCCAACAACTCTGCAAGCACCATTTTACCATCCTCCGM 1 24 C
A C
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A C
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A C
T 6 GC AGC CA T
. . . . . . . . . . . . . . . .CCII -1249 . C* ****@*C**6*C..-C-T. e .*.* ** . C*G*e*6*§****CAGCTCACT ^ z*e@ @ e X*
MCA - I1136 CTT1.VACAAATCACGCAATCAAGCATCATAGAAGCCAAGTG ACTTGTCCAAGTCAACATACTTAAGTGACAGAACCATTAGCTGAGCCCAGGTCTATATCTGCATATAAATTCCATGCT
CCtI 112§9 .....................................
- ee @ @*...*......*.........*..*.......*.-......-...-. TC-...*... - C *-...*..CC ..*..*CGTT ..*. Y
RCA - ¶01 7 TA**CCA*CTATATAAGCCTTTCCCAAAACTGATTTCAGGTGAAACATAAATAAACTT TTAAGTTTAACTGIGTTTATTTTAACGCATGACACGAAAAAAAATTAAGCACACC0I1 -loll......G-G-C...A---A......T'.-C.--G.....G-G... TTTAAAAAC..T.A.ACTTA C..C......TAT. C.TT.AGC....CT.Y.....
MCA -906 A TCAAATCTCTCAT T TCATCGACAATAT TGCATAAGACAAAAATAT T TTGTCTTCAGTTCCTGCCCTCAAGCCATCCTCTCACCTCAACCTCTTGTACACCYCACATCACACCTGTCACC
CCR1 - 892 ........ .GA ............................GG--G.c.... C-C.....................C. .. . AT G. . . . C.........G........AC
MCA - 786 CACCAAC*CCCTGCTAAGACAAGGATGTTTTGTAAACTAAATTTAATTACAAAAAAAGTATGAAGTAAATAATAATAAACGGTGGTA AAGCTCTAGAGAAAATCATAAAGTTGGCTCAGAAC - CG G T G G TA T CC
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MCA^ -66 A^T GT C TGGGGCTCTGCGATGACAT AAYTACTACAGCAT CATGCCAGC T TCA T TCTCACT TAC TCCCASGAAAT TAGAGT CACATAACACTGCAGAAAiACAA^T TCAGAAT C T7AGACCCGGGC
C 5 .T............ G........Cl .............. . . . . . TG . . .Y. .§. . . .-. . . . GCCA. .@. .v. .@.@-@.6. . .sveTC--@ C*- ---- sT*
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ICA -427 GTCCGCCGAAA AACACAGTGGACCC AGGGACTCTCTG* 4 ** * C TGA*8*c* CAGA*cCCAG CCCAGCACAGAAG*c^GT+%C*CGTGC *GGAGACGT*CGTC
C'E A - 3§t9* . . . . . . . . . . . . . . G . . . A *- -TC *CCT . . . . . . . . . . . . . . . . . . A-AG.. . . . . . . . . . . . . A--CA . . . . . . .@A--CA-* T
ICA -30 CTGTCTATGGAAcrCAGGGGT CCAAACAAG C TTCC T T CCAGAGCATC TTCt CCCAC^CT GA^&tA C^^^CAGA GGAAGGAGACA^6SACCC ^AAAAACAGAAA^TC&AGAGGGGAGGGG
c t - 3O0 GCCACAs @GGAT . . .vGT * C T * C*-C .....-AA-TT . . . . .Cs^sAtTG G A*s A**6..^A^ . . . . . . . . . . . . . . .GC . . . . . . . . . . §
NCA - 190 ATAC*AGGAT C CTGACACAGAGACCGCACCCATG;ACC CACCGTG6ACCCrGCCGAAA^TGCrT cT AT CCCt;CGACACA6GCCTCIZltillAGGAGGAAGACAGcCAGGGCCACAtG T CACAC
OCAI -772 CAGCCCTGACGGA CGACCACTCCAAAAGGAAAAG.*. ACAG C G CC .
:CG1 6 21 ......... C. .. G..C G...... C. **T........... so*
:EA -189 CCC*AaG *C................ ... ............. C ...............CV'.s
CA -4z27CC^I TCICT CI CAG^CACAGAAAAC CCIACACtCA^^CC TICACFCTACCC^A^CCACTGTC TCC ICTCAGACAAG^c^GCI CT^CA^CACACCACCACCCCAACTCTCCCACCC
CIA*T*-391 . s vvA**.. * **IC* ** * * *T* * ** A AC. ~ A *ACA c** ****T
FIG. 5. Comparison of the nucleotide sequences from the putative promoter regions of the NCA, CEA, and CGM1 genes. The numbers
indicate the distance in nucleotides from the initiation codon for each gene. Gaps have been introduced to allow optimal alignment. Identical
nucleotides are indicated by dots. The cluster of transcriptional start sites determined for CEA and NCA in the S1 nuclease assays (see Fig.
4 and text) are designated (arrows). Consensus TATA sequences for the NCA and CEA genes, as well as the initiation codons, are shaded
grey.
3' untranslated region of an NCA cDNA clone (60) may not
be NCA mRNA specific.
Recently, we found that after stable transfection of this
CEA cosmid clone into Chinese hamster ovary (CHO) cells,
a 180,000-molecular-weight glycosylated CEA molecule was
expressed on the cell surface (L. J. F. Hefta, H. Schrewe,
J. A. Thompson, S. Oikawa, H. Nakazato, and J. E.
Shively, Cancer Res., in press). These results show that a
functional promoter is probably present in the 3,300-nucle-
otide region upstream of the translational start contained
within this cosmid clone (Fig. 1). Although a rapid sequence
divergence between the human and rodent CEA families has
been reported, which indicates a parallel but independent
evolution of the genes in different mammalian orders (39),
these expression results suggest that the trans-acting factors
and cis-acting elements responsible for activating the CEA
gene are conserved enough between humans and rodents to
allow expression across species. Therefore, closer analysis
of the regulation of human CEA gene expression in a rodent
system is feasible. Furthermore, the encoded CEA molecule
was apparently posttranslationally modified through addition
of a phosphatidylinositol glycan tail, as for the native CEA
molecule (Hefta et al., in press). These results indicate that
all the information needed for the correct expression of the
CEA gene is contained within cosCEAL.
To define the actual portion of the 5' untranslated region
which is required for the promoter activity of the CEA gene
and, for comparison, that of a closely related NCA gene, we
carried out functional tests by placing restriction endonucle-
ase fragments of various lengths from the putative promoter
regions of both genes upstream of the CAT reporter gene and
assaying for CAT activity in a transient transfection assay in
two different human cell lines (Fig. 6). For this purpose, we
chose the CEA-producing adenocarcinoma cell line SW403
and, as a negative control, the HeLa cell line. No significant
differences in the promoter activities could be determined
between the cell lines with the NCA constructs used. These
seem to contain only a basal level of promoter activity,
especially for the shortest construct, which showed minimal
activity (Fig. 6). On the other hand, the CEA promoter
constructs showed an enhanced expression of the CAT gene
in SW403 cells, which was nine times greater than in HeLa
cells, when the shortest construct was used (Fig. 6,
pCEA424/2CAT). It appears that cis regulatory sequences,
which are responsible for this enhancement, along with a
functional transcription initiator, are both present within the
first 424 nucleotides upstream of the translational start.
When the sequences in this region of the CEA and NCA
genes were compared, homology was found (Fig. 5 and 6);
however, regions showing stronger sequence divergence
also exist in the region upstream of -240 nucleotides from
the translational start of the CEA gene, which may be of
interest regarding the differential regulation of expression of
the two genes. Further experiments must be designed to
analyze these regions more closely. It is also interesting that
the longer CEA constructs are approximately 50% less
active in their promoter activities in SW403 cells and 25%
less active in HeLa cells than is the pCEA424/2CAT con-
struct (Fig. 6). A possible explanation for this phenomenon
is that a silencer region could exist between nucleotides
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FIG. 6. Determination of the CEA and NCA gene promoters through transient-transfection assays in SW403 and HeLa cells. The regions
analyzed for both genes are indicated (LI1), and the positions of the initiation codons are shown. Regions of sequence homology are shown
(M). The following restriction endonuclease sites were used for the constructs: BstXI, (Bs), EcoRI (E), HindIll (H), NcoI (N), PstI (P),
SstI (S), and degenerate MspI cloning sites [(M)]. A rare-cutting restriction endonuclease site (SacII) found in the C+G-rich CEA promoter
is shown (Sc). The arrows indicate the transcriptional starts and orientation. The fragments of each gene promoter spliced in front of the
promoterless CAT reporter gene are shown (. .). The CAT activity was determined for each construct after transient transfection into SW403
cells (Lii) and HeLa cells (_). The activities are expressed as a percentage of the CAT activity obtained with the plasmid pSV2CAT (see
text), which was equivalent to a mean of 30,000 dpm in SW403 or 50,000 dpm in HeLa cells (ca. 30 and 50% conversion of the acetyl coenzyme
A added, respectively; this was the limiting factor). Up to five separate assays were carried out for each construct to confirm reproducibility.
Standard deviations are indicated with bars.
-424 and -832 upstream from the translational start, which
reduces the activities in both cell lines through interaction
with common trans-acting regulatory factors. Such silencer
sequences have indeed been described for other genes (8, 9).
However, further studies must be carried out to analyze this
in more detail.
As found here for CEA and NCA, a number of other
eucaryotic genes have also been reported which do not
contain obvious TATA boxes. The promoters of such genes
can be divided into two classes (42). The members of the first
class are G+C rich and are found primarily in housekeeping
genes (41). These promoters usually contain several tran-
scription initiation sites spread over a fairly large region, as
well as potential binding sites for Spl (11). The members of
the second class are not G+C rich, are not constitutively
active, but are regulated during differentiation or develop-
ment and initiate transcription at only one or a few tightly
clustered start sites (42). Included in this class are a number
of genes that are regulated during mammalian immunodiffer-
entiation, e.g., the T-cell receptor 1-chain genes (1) and the
VpreB gene (22), as well as some Drosophila homeotic genes
(6, 38, 43). The CEA and NCA genes show a closer resem-
blance to this latter group, because their promoters are not
obviously G+C rich, they contain no identifiable Spl-
binding sites, they reveal only a few tightly clustered start
sites, and, most importantly, they are not constitutively
expressed.
Future experiments will concentrate on more closely
defining the various regions of interest in the promoters and,
in parallel, will be directed toward identifying regions which
possibly convey an oncofetally regulated expression pattern
of the CEA gene.
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